We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Bioproduction
The Path Towards Affordable Advanced Therapies
Erik Vaessen, Head of Sales and Marketing – Bioproduction, and Cell & Gene Therapy at FUJIFILM Irvine Scientific, recently spoke with Phacilitate—a market Read more...BioInformant Goes Behind the Scenes at FUJIFILM Irvine Scientific
FUJIFILM Irvine Scientific CEO Yutaka Yamaguchi interviewed by Bioinformant
Yutaka Yamaguchi, CEO of FUJIFILM Irvine Scientific, was recently invited to sit down Read more...Leading Industry Experts Address Cell and Gene Therapy Raw Materials Supply Chain Needs
Recently Marlin Frechette, FUJIFILM Irvine Scientific's Sr. Director of Quality Systems/Regulatory Affairs/Compliance Officer & ISO Management Representative, Read more...Cell Culture Experts Share Insights and Look into the Future of Media Development
Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific recently participated in a panel discussion among cell culture media experts about current Read more...Media Survey versus Media Screen: The Key Differences Between the Two Strategies
We recently sat down with Catherine Nguyen, a rising scientist at Irvine Scientific who oversees our Media Survey Panel program, to discuss the key differences Read more...Cohesive Control of Antibody Galactosylation for Improved Antibody Product Quality and Function
Protein-based therapeutics are dominating the pharmaceutical market due to their high-efficacy in treating complex diseases.1 The demand for antibody (Ab) drugs Read more...Cell, Media, and Process – The Three Musketeers of Cell Culture
Optimal cell culture performance requires the cells, the media, and the process all work together closely in harmony. Much like the legendary Three Musketeers from Read more...
Recent Posts
-
Moving Beyond Animal Models with iPSC-based Models: Shifts and New Challenges -
Patient-derived Organoids for Cell Therapy Development: The Needs Behind the Innovation -
How Monoclonal Antibodies Have Transformed Breast Cancer Treatment, and Where is it Going Next -
Meet the Team: Interview with Brandon Pence – President and Chief Operating Officer -
Meet the Team: Interview with Robert Hodge – Senior Director, Corporate Planning
